









市場行情
/
股票
/
nasdaq-ecor
/

electroCore, Inc.

ECOR

4.600USD

+0.180+4.07%

收盤 12/19, 16:00（美東）報價延遲15分鐘

35.12M總市值

虧損本益比TTM



electroCore, Inc.

4.600

+0.180+4.07%

概覽公司財務分析

概覽

公司

財務

分析

關於 electroCore, Inc. 公司

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

electroCore, Inc.簡介



公司代碼ECOR

公司名稱electroCore, Inc.

上市日期Jun 22, 2018

CEOGoldberger (Daniel S)

員工數量73

證券類型Ordinary Share

年結日Jun 22

公司地址200 Forge Way

城市ROCKAWAY

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編07866

電話19732900097

網址https://www.electrocore.com/

公司代碼ECOR

上市日期Jun 22, 2018

CEOGoldberger (Daniel S)

electroCore, Inc.公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Daniel S. (Dan) Goldberger

Chief Executive Officer, Director

185.90K

+0.54%

Mr. Thomas M. (Tom) Patton, J.D.

Independent Director

102.78K

+22.69%

Mr. John P. Gandolfo

Independent Director

88.10K

+27.52%

Ms. Patricia Wilber

Independent Director

72.33K

+35.66%

Ms. Elena Bonfiglioli

Director

30.55K

Dr. Thomas J. Errico, M.D.

Independent Chairman of the Board

Mr. Joshua S. Lev

Chief Financial Officer

Ms. Julie A. Goldstein

Independent Director

Mr. James C. Theofilos

Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Daniel S. (Dan) Goldberger

Chief Executive Officer, Director

185.90K

+0.54%

Mr. Thomas M. (Tom) Patton, J.D.

Independent Director

102.78K

+22.69%

Mr. John P. Gandolfo

Independent Director

88.10K

+27.52%

Ms. Patricia Wilber

Independent Director

72.33K

+35.66%

Ms. Elena Bonfiglioli

Director

30.55K

Dr. Thomas J. Errico, M.D.

Independent Chairman of the Board

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

Rx gammaCore - Department of Veteran Affairs and Department of Defense

5.18M

70.25%

Truvaga

994.00K

13.47%

Outside the United States

465.00K

6.30%

Rx gammaCore - U.S. Commercial

394.00K

5.34%

TAC-STIM

181.00K

2.45%

其他

162.00K

2.19%

地區USD

名稱

營收

佔比

United States

6.89M

93.42%

United Kingdom

433.00K

5.87%

Other

36.00K

0.49%

Japan

17.00K

0.23%

業務

地區

業務USD

名稱

營收

佔比

Rx gammaCore - Department of Veteran Affairs and Department of Defense

5.18M

70.25%

Truvaga

994.00K

13.47%

Outside the United States

465.00K

6.30%

Rx gammaCore - U.S. Commercial

394.00K

5.34%

TAC-STIM

181.00K

2.45%

其他

162.00K

2.19%

股東統計

更新時間: 11月18日週二

持股股東

股東類型

持股股東

佔比

Zhang (Tianyi)

9.19%

Theofilos (Charles Steve)

5.56%

Hilve Holdings Ltd

5.40%

Errico (Thomas J.)

3.83%

The Vanguard Group, Inc.

2.92%

其他

73.10%

持股股東

佔比

Zhang (Tianyi)

9.19%

Theofilos (Charles Steve)

5.56%

Hilve Holdings Ltd

5.40%

Errico (Thomas J.)

3.83%

The Vanguard Group, Inc.

2.92%

其他

73.10%

股東類型

持股股東

佔比

Individual Investor

26.93%

Corporation

8.76%

Investment Advisor

6.05%

Hedge Fund

1.57%

Investment Advisor/Hedge Fund

1.36%

Research Firm

0.02%

其他

55.31%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

727.72K

16.70%

2025Q3

727.72K

17.61%

-444.98K

2025Q2

1.17M

19.50%

-199.13K

2025Q1

1.37M

13.77%

+380.78K

2024Q4

936.59K

18.00%

-138.83K

2024Q3

1.06M

17.69%

+20.62K

2024Q2

1.04M

19.14%

+51.56K

2024Q1

992.08K

19.07%

-152.78K

2023Q4

961.96K

18.72%

+22.04K

2023Q3

937.71K

13.66%

+316.94K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Zhang (Tianyi)

734.64K

9.25%

+734.64K

May 15, 2025

Theofilos (Charles Steve)

444.53K

5.6%

Jul 04, 2025

Hilve Holdings Ltd

432.00K

5.44%

+432.00K

Aug 15, 2025

Errico (Thomas J.)

306.38K

3.86%

+26.61K

+9.51%

Sep 02, 2025

The Vanguard Group, Inc.

232.33K

2.92%

Jun 30, 2025

Goldberger (Daniel S)

184.90K

2.33%

+1.00K

+0.54%

Aug 11, 2025

Happy Holstein Management, LLC

153.17K

1.93%

Jul 04, 2025

MAZ Partners, L.P.

115.52K

1.45%

-156.44K

-57.52%

May 13, 2025

Patton (Thomas M)

102.78K

1.29%

+19.01K

+22.69%

Sep 02, 2025

Goldstein (Julie Ann)

101.39K

1.28%

+19.01K

+23.08%

Sep 02, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

iShares Micro-Cap ETF

佔比0%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

公告日期

類型

比率

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

Feb 14, 2023

Merger

15→1

常見問題

electroCore, Inc.的前五大股東是誰？



electroCore, Inc.的前五大股東如下：
Zhang (Tianyi)
持有股份：734.64K
佔總股份比例：9.25%。
Theofilos (Charles Steve)
持有股份：444.53K
佔總股份比例：5.60%。
Hilve Holdings Ltd
持有股份：432.00K
佔總股份比例：5.44%。
Errico (Thomas J.)
持有股份：306.38K
佔總股份比例：3.86%。
The Vanguard Group, Inc.
持有股份：232.33K
佔總股份比例：2.92%。